SPARC is a possible predictive marker for albumin-bound paclitaxel in non-small-cell lung cancer

OBJECTIVES: Nanoparticle albumin-bound paclitaxel (nab-paclitaxel) produced good tumor response in cases with lung squamous cell carcinoma, one of the most difficult cancers to treat. Secreted protein acidic and rich in cysteine (SPARC) binds to albumin, suggesting that SPARC plays an important role...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Onco Targets Ther
Hlavní autoři: Komiya, Kazutoshi, Nakamura, Tomomi, Nakashima, Chiho, Takahashi, Koichiro, Umeguchi, Hitomi, Watanabe, Naomi, Sato, Akemi, Takeda, Yuji, Kimura, Shinya, Sueoka-Aragane, Naoko
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2016
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5089830/
https://ncbi.nlm.nih.gov/pubmed/27822069
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S114492
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky